Triple
T32196364
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | avelumab |
E822413
|
entity |
| Predicate | combinationIndication |
P113308
|
FINISHED |
| Object | first-line treatment of advanced renal cell carcinoma with axitinib |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: first-line treatment of advanced renal cell carcinoma with axitinib | Statement: [avelumab, combinationIndication, first-line treatment of advanced renal cell carcinoma with axitinib]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: combinationIndication Context triple: [avelumab, combinationIndication, first-line treatment of advanced renal cell carcinoma with axitinib]
-
A.
treatmentIndication
chosen
Indicates that a treatment is intended to address, alleviate, or prevent a particular condition, symptom, or medical indication.
-
B.
combinationType
Indicates how multiple elements are combined or related to each other within a composite structure or operation.
-
C.
indicatedFor
Indicates...that one entity (typically a treatment, procedure, or product) is recommended or appropriate for use in relation to another entity (such as a condition, symptom, or patient group).
-
D.
hasContraindication
Indicates that one entity (such as a treatment, drug, or procedure) should not be used or performed in the presence of another entity (such as a condition, factor, or co-medication) because it may cause harm or adverse effects.
-
E.
mayBeComorbidWith
Indicates that two conditions or disorders can occur together in the same individual, potentially influencing each other’s presence or severity.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f349093174819086e633c190a51aa8 |
completed | April 30, 2026, 12:20 p.m. |
| NER | Named-entity recognition | batch_69f6bb3795fc8190bfcb00d45aa887a1 |
completed | May 3, 2026, 3:04 a.m. |
| PD | Predicate disambiguation | batch_69f6b6293188819080d5041ca0adb969 |
completed | May 3, 2026, 2:42 a.m. |
Created at: May 1, 2026, 12:36 a.m.